Fonds Themen
Themenfonds
Themenfonds
| Abaris Biotechnology Opportunities A CHF | CHF | Aktienfonds | - | 93.97 | -0.06% | +25.16% | +39.90% | +60.77% | +132.14% |
| Abaris Biotechnology Opportunities A USD | USD | Aktienfonds | - | 102.17 | -0.88% | +18.21% | +33.42% | +53.64% | +156.13% |
| Janus Henderson Horizon Biotechnology Fund GU2 EUR | EUR | Aktienfonds | - | 34.63 | +1.26% | +15.01% | +17.39% | +52.42% | - |
| Janus Henderson Horizon Biotechnology Fund S2 EUR | EUR | Aktienfonds | - | 34.29 | +1.27% | +14.41% | +17.39% | +51.99% | - |
| Janus Henderson Horizon Biotechnology Fund IU2 EUR | EUR | Aktienfonds | - | 33.03 | +1.29% | +14.81% | +17.21% | +51.65% | +87.24% |
| Janus Henderson Horizon Biotechnology Fund A2 EUR | EUR | Aktienfonds | - | 32.38 | +1.28% | +14.22% | +16.77% | +50.60% | +84.92% |
| Janus Henderson Horizon Biotechnology Fund GU2 GBP | GBP | Aktienfonds | - | 35.81 | +1.36% | +12.97% | +15.78% | +49.96% | - |
| UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse (SEK) P-acc, SEK | SEK | Aktienfonds | - | 1'371.23 | +1.33% | +31.22% | +30.16% | +49.86% | +51.30% |
| Janus Henderson Horizon Biotechnology Fund GU2 USD | USD | Aktienfonds | - | 36.11 | +1.09% | +11.24% | +16.18% | +47.09% | - |
| Janus Henderson Horizon Biotechnology Fund E2 USD | USD | Aktienfonds | - | 42.35 | +1.07% | +11.30% | +16.12% | +46.90% | +104.59% |
| Janus Henderson Horizon Biotechnology Fund IU2 USD | USD | Aktienfonds | - | 40.93 | +1.09% | +11.04% | +15.95% | +46.49% | +102.02% |
| Janus Henderson Horizon Biotechnology Fund H2 USD | USD | Aktienfonds | - | 40.31 | +1.08% | +10.83% | +15.80% | +46.16% | +101.05% |
| Janus Henderson Horizon Biotechnology Fund S2 USD | USD | Aktienfonds | - | 35.61 | +1.11% | +10.69% | +15.80% | +46.06% | - |
| Janus Henderson Horizon Biotechnology Fund GU2 HEUR | EUR | Aktienfonds | - | 35.09 | +1.09% | +9.90% | +15.31% | +45.97% | - |
| Janus Henderson Horizon Biotechnology Fund A2 USD | USD | Aktienfonds | - | 39.55 | +1.07% | +10.41% | +15.51% | +45.40% | +98.25% |
| Pictet - Biotech - Z EUR | EUR | Aktienfonds | - | 1'826.81 | +0.78% | +15.06% | +14.90% | +44.89% | - |
| Janus Henderson Horizon Biotechnology Fund E2 HEUR | EUR | Aktienfonds | - | 36.34 | +1.08% | +10.02% | +15.29% | +44.67% | +94.96% |
| Janus Henderson Horizon Biotechnology Fund IU2 HEUR | EUR | Aktienfonds | - | 36.62 | +1.08% | +9.74% | +15.08% | +44.46% | +88.18% |
| Janus Henderson Horizon Biotechnology Fund H2 HEUR | EUR | Aktienfonds | - | 30.59 | +1.09% | +9.56% | +14.96% | +43.75% | +90.95% |
| Pictet - Biotech - I EUR | EUR | Aktienfonds | - | 1'582.76 | +0.78% | +14.21% | +14.33% | +43.46% | +84.37% |
| PMG Helix Biotechnology Fund I USD | USD | Aktienfonds | - | 133.32 | +0.85% | +17.78% | +19.17% | +43.40% | +64.37% |
| Candriam Equities L Biotechnology, R - Capitalisation | EUR | Aktienfonds | - | 508.51 | -0.25% | +19.88% | +19.16% | +43.37% | +77.35% |
| UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse QL-acc, USD | USD | Aktienfonds | - | 159.68 | +0.77% | +22.47% | +25.43% | +43.34% | +72.44% |
| Candriam Equities L Biotechnology, I - Capitalisation | EUR | Aktienfonds | - | 3'429.13 | -0.25% | +20.05% | +19.36% | +43.17% | +74.23% |
| PMG Helix Biotechnology Fund R USD | USD | Aktienfonds | - | 139.44 | +0.85% | +17.61% | +19.06% | +43.12% | +63.41% |
| UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse Q-acc, USD | USD | Aktienfonds | - | 488.82 | +0.77% | +22.29% | +25.30% | +43.06% | +71.40% |
| Janus Henderson Horizon Biotechnology Fund A2 HEUR | EUR | Aktienfonds | - | 29.73 | +1.05% | +9.10% | +14.65% | +43.00% | +87.10% |
| JPMorgan Funds - Thematics - Genetic Therapies I (acc) - EUR | EUR | Aktienfonds | - | 87.19 | +0.50% | +23.53% | +24.20% | +42.40% | +33.85% |
| Pictet - Biotech - P EUR | EUR | Aktienfonds | - | 1'286.02 | +0.78% | +13.45% | +13.82% | +42.19% | +79.51% |
| Candriam Equities L Biotechnology, C - Capitalisation | EUR | Aktienfonds | - | 337.17 | -0.25% | +19.06% | +18.60% | +42.04% | +72.46% |
| UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse P-acc, USD | USD | Aktienfonds | - | 1'077.02 | +0.76% | +21.37% | +24.67% | +41.61% | +66.23% |
| Pictet - Biotech - R EUR | EUR | Aktienfonds | - | 1'083.61 | +0.78% | +12.85% | +13.42% | +41.19% | +75.73% |
| Pictet - Biotech - I dy GBP | GBP | Aktienfonds | - | 1'357.22 | +0.87% | +12.15% | +12.74% | +40.78% | +82.54% |
| Candriam Equities L Biotechnology, R - Capitalisation | GBP | Aktienfonds | - | 562.97 | -0.21% | +17.81% | +17.70% | +40.73% | +75.42% |
| Candriam Equities L Biotechnology, I - Capitalisation | GBP | Aktienfonds | - | 5'293.74 | -0.21% | +18.00% | +17.88% | +40.55% | +72.36% |
| Franklin Biotechnology Discovery Fund - I (acc) USD | USD | Aktienfonds | - | 107.33 | -0.66% | +12.27% | +16.33% | +40.39% | +107.60% |
| Franklin Biotechnology Discovery Fund - A (acc) HKD | HKD | Aktienfonds | - | 43.27 | -0.64% | +12.48% | +15.97% | +40.35% | +102.76% |
| Franklin Biotechnology Discovery Fund - W (acc) USD | USD | Aktienfonds | - | 33.50 | -0.65% | +12.23% | +16.32% | +40.34% | +107.30% |
| PMG Helix Biotechnology Fund I-N USD | USD | Aktienfonds | - | 155.79 | +0.85% | +18.05% | +6.82% | +40.10% | - |
| Pictet - Biotech - Z USD | USD | Aktienfonds | - | 2'072.19 | +0.59% | +11.27% | +13.68% | +39.96% | +103.64% |
| JPMorgan Funds - Thematics - Genetic Therapies C (dist) - GBP | GBP | Aktienfonds | - | 83.39 | +0.59% | +21.28% | +22.45% | +39.70% | +32.33% |
| Pictet - Biotech - P dy GBP | GBP | Aktienfonds | - | 1'102.23 | +0.86% | +11.41% | +12.24% | +39.54% | +77.73% |
| PMG Helix Biotechnology Fund B USD | USD | Aktienfonds | - | 155.04 | +0.85% | +17.66% | +6.60% | +39.50% | - |
| Candriam Equities L Biotechnology, R - Capitalisation | USD | Aktienfonds | - | 440.44 | +0.61% | +16.29% | +18.41% | +39.25% | +89.98% |
| Franklin Biotechnology Discovery Fund - A (acc) USD | USD | Aktienfonds | - | 66.18 | -0.66% | +11.56% | +15.84% | +39.21% | +102.39% |
| JPMorgan Funds - Thematics - Genetic Therapies C2 (dist) - GBP (hedged) | GBP | Aktienfonds | - | 136.69 | +0.36% | +20.47% | +23.27% | +39.15% | +43.22% |
| JPMorgan Funds - Thematics - Genetic Therapies C2 (acc) - GBP (hedged) | GBP | Aktienfonds | - | 138.76 | +0.36% | +20.47% | +23.28% | +39.15% | +43.23% |
| Candriam Equities L Biotechnology, I - Capitalisation | USD | Aktienfonds | - | 9'167.70 | +0.61% | +16.43% | +18.57% | +39.02% | +86.65% |
| Candriam Equities L Biotechnology, V2 - Capitalisation | USD | Aktienfonds | - | 3'042.05 | -0.46% | +15.97% | +18.01% | +38.95% | +91.39% |
| Candriam Equities L Biotechnology, V - Capitalisation | USD | Aktienfonds | - | 3'346.28 | -0.46% | +16.07% | +18.14% | +38.65% | +87.40% |
| Pictet - Biotech - I USD | USD | Aktienfonds | - | 1'794.22 | +0.59% | +10.45% | +13.11% | +38.57% | +97.66% |
| JPMorgan Funds - Thematics - Genetic Therapies A (acc) - GBP (hedged) | GBP | Aktienfonds | - | 133.65 | +0.35% | +19.96% | +22.92% | +38.35% | +40.86% |
| JPMorgan Funds - Thematics - Genetic Therapies A (dist) - GBP (hedged) | GBP | Aktienfonds | - | 133.59 | +0.35% | +19.96% | +22.92% | +38.35% | +40.87% |
| Pictet - Biotech - HR dm ZAR | ZAR | Aktienfonds | - | 10'574.42 | +0.57% | +10.24% | +13.09% | +38.26% | +97.48% |
| Franklin Biotechnology Discovery Fund - N (acc) USD | USD | Aktienfonds | - | 53.83 | -0.65% | +10.94% | +15.42% | +38.17% | +97.90% |
| Franklin Biotechnology Discovery Fund - A (acc) SGD | SGD | Aktienfonds | - | 61.60 | -0.61% | +10.93% | +14.65% | +37.90% | +89.19% |
| Franklin Biotechnology Discovery Fund - F (acc) USD | USD | Aktienfonds | - | 20.43 | -0.68% | +10.73% | +15.23% | +37.76% | +96.44% |
| JPMorgan Funds - Thematics - Genetic Therapies I2 (acc) - USD | USD | Aktienfonds | - | 101.01 | +0.31% | +19.55% | +22.94% | +37.69% | +43.87% |
| JPMorgan Funds - Thematics - Genetic Therapies C2 (acc) - USD | USD | Aktienfonds | - | 137.92 | +0.31% | +19.53% | +22.92% | +37.64% | +43.71% |
| JPMorgan Funds - Thematics - Genetic Therapies C2 (dist) - USD | USD | Aktienfonds | - | 135.98 | +0.30% | +19.52% | +22.92% | +37.64% | +43.70% |
| JPMorgan Funds - Thematics - Genetic Therapies C (dist) - USD | USD | Aktienfonds | - | 79.73 | +0.30% | +19.42% | +22.85% | +37.50% | +43.29% |
| JPMorgan Funds - Thematics - Genetic Therapies C (acc) - USD | USD | Aktienfonds | - | 111.62 | +0.31% | +19.42% | +22.85% | +37.50% | +43.30% |
| Candriam Equities L Biotechnology, C - Thesaurierung | USD | Aktienfonds | - | 1'351.88 | -0.46% | +15.00% | +17.34% | +37.39% | +85.00% |
| Pictet - Biotech - P USD | USD | Aktienfonds | - | 1'458.52 | +0.59% | +9.72% | +12.61% | +37.35% | +92.45% |
| Pictet - Biotech - P dy USD | USD | Aktienfonds | - | 1'457.98 | +0.59% | +9.72% | +12.61% | +37.35% | +92.44% |
| Candriam Equities L Biotechnology, C - Distribution | USD | Aktienfonds | - | 1'220.43 | -0.46% | +14.97% | +17.32% | +37.34% | +84.82% |
| Franklin Biotechnology Discovery Fund - N (acc) PLN-H1 | PLN | Aktienfonds | - | 15.56 | -0.64% | +10.20% | +14.92% | +37.33% | +97.96% |
| Franklin Biotechnology Discovery Fund - I (acc) EUR-H1 | EUR | Aktienfonds | - | 38.75 | -0.67% | +10.34% | +15.02% | +37.22% | +95.21% |
| JPMorgan Funds - Thematics - Genetic Therapies A (acc) - HKD (hedged) | HKD | Aktienfonds | - | 13.27 | +0.30% | +18.80% | +22.08% | +37.09% | +37.94% |
| Pictet - Biotech - HI CZK | CZK | Aktienfonds | - | 23'765.19 | +0.59% | +9.63% | +12.60% | +37.02% | - |
| JPMorgan Funds - Thematics - Genetic Therapies A (acc) - USD | USD | Aktienfonds | - | 133.43 | +0.31% | +19.05% | +22.60% | +36.92% | +41.57% |
| JPMorgan Funds - Thematics - Genetic Therapies I2 (acc) - EUR (hedged) | EUR | Aktienfonds | - | 120.02 | +0.35% | +19.08% | +22.38% | +36.90% | +36.98% |
| Candriam Equities L Biotechnology, N - Capitalisation | USD | Aktienfonds | - | 954.87 | -0.46% | +14.69% | +17.12% | +36.90% | +83.00% |
| JPMorgan Funds - Thematics - Genetic Therapies A (dist) - USD | USD | Aktienfonds | - | 132.75 | +0.30% | +19.01% | +22.57% | +36.87% | +41.34% |
| JPMorgan Funds - Thematics - Genetic Therapies C2 (dist) - EUR (hedged) | EUR | Aktienfonds | - | 124.98 | +0.35% | +19.04% | +22.37% | +36.85% | +36.82% |
| JPMorgan Funds - Thematics - Genetic Therapies C2 (acc) - EUR (hedged) | EUR | Aktienfonds | - | 126.72 | +0.36% | +19.05% | +22.36% | +36.85% | +36.82% |
| JPMorgan Funds - Thematics - Genetic Therapies I (acc) - EUR (hedged) | EUR | Aktienfonds | - | 84.35 | +0.36% | +18.99% | +22.32% | +36.75% | +36.60% |
| JPMorgan Funds - Thematics - Genetic Therapies C (acc) - EUR (hedged) | EUR | Aktienfonds | - | 102.88 | +0.35% | +18.94% | +22.30% | +36.68% | +36.43% |
| Polar Capital Funds plc - Biotechnology Fund Class I EUR Distribution Shares | EUR | Aktienfonds | - | 65.80 | -0.47% | +14.57% | +18.20% | +36.40% | +90.89% |
| Pictet - Biotech - R USD | USD | Aktienfonds | - | 1'229.23 | +0.59% | +9.14% | +12.21% | +36.38% | +88.41% |
| Franklin Biotechnology Discovery Fund - A (acc) EUR-H1 | EUR | Aktienfonds | - | 18.44 | -0.65% | +9.70% | +14.53% | +36.19% | +90.30% |
| JPMorgan Funds - Thematics - Genetic Therapies A (acc) - EUR (hedged) | EUR | Aktienfonds | - | 122.58 | +0.35% | +18.57% | +22.03% | +36.11% | +34.76% |
| JPMorgan Funds - Thematics - Genetic Therapies A (dist) - EUR (hedged) | EUR | Aktienfonds | - | 121.97 | +0.35% | +18.54% | +22.00% | +36.06% | +34.56% |
| Pictet - Biotech - HP CZK | CZK | Aktienfonds | - | 21'620.60 | +0.59% | +8.91% | +12.10% | +35.80% | - |
| JPMorgan Funds - Thematics - Genetic Therapies C2 (acc) - SGD (hedged) | SGD | Aktienfonds | - | 13.24 | +0.38% | +18.21% | +21.80% | +35.79% | +35.38% |
| Polar Capital Funds plc - Biotechnology Fund Class R EUR Distribution Shares | EUR | Aktienfonds | - | 62.12 | -0.46% | +14.13% | +17.90% | +35.72% | +88.41% |
| Pictet - Biotech - HI EUR | EUR | Aktienfonds | - | 925.37 | +0.60% | +8.80% | +12.01% | +35.68% | +84.79% |
| Pictet - Biotech - HR AUS | AUD | Aktienfonds | - | 1'157.19 | +0.58% | +8.90% | +12.20% | +35.67% | +80.38% |
| Candriam Equities L Biotechnology, R-H - Capitalisation | EUR | Aktienfonds | - | 319.71 | -0.47% | +13.91% | +16.64% | +35.52% | +77.57% |
| JPMorgan Funds - Thematics - Genetic Therapies D (acc) - USD | USD | Aktienfonds | - | 89.17 | +0.30% | +18.14% | +21.97% | +35.50% | +37.16% |
| Candriam Equities L Biotechnology, I-H - Capitalisation | EUR | Aktienfonds | - | 3'168.51 | -0.47% | +14.06% | +16.85% | +35.38% | +74.79% |
| Galileo - Biotech Innovation Fund BC USD | USD | Aktienfonds | - | 71.22 | +0.24% | +23.35% | +28.37% | +35.04% | +44.11% |
| JPMorgan Funds - Thematics - Genetic Therapies A (acc) - SGD (hedged) | SGD | Aktienfonds | - | 12.73 | +0.32% | +17.65% | +21.35% | +34.99% | +33.02% |
| JPMorgan Funds - Thematics - Genetic Therapies D (acc) - EUR (hedged) | EUR | Aktienfonds | - | 96.06 | +0.34% | +17.69% | +21.43% | +34.75% | +30.75% |
| Pictet - Biotech - HP EUR | EUR | Aktienfonds | - | 841.87 | +0.60% | +8.08% | +11.51% | +34.48% | +79.92% |
| Candriam Equities L Biotechnology, C-H - Capitalisation | EUR | Aktienfonds | - | 300.63 | -0.47% | +13.20% | +16.15% | +34.38% | +73.17% |
| Franklin Biotechnology Discovery Fund - A (acc) JPY-H1 | JPY | Aktienfonds | - | 1'631.92 | -0.66% | +8.75% | +13.84% | +34.34% | - |
| JPMorgan Funds - Thematics - Genetic Therapies C2 (dist) - CHF (hedged) | CHF | Aktienfonds | - | 114.15 | +0.35% | +17.27% | +21.20% | +33.94% | +28.48% |
| JPMorgan Funds - Thematics - Genetic Therapies C2 (acc) - CHF (hedged) | CHF | Aktienfonds | - | 115.75 | +0.36% | +17.26% | +21.19% | +33.94% | +28.48% |
| Galileo - Biotech Innovation Fund S USD | USD | Aktienfonds | - | 68.76 | +0.25% | +22.52% | +27.83% | +33.93% | +41.25% |
| Polar Capital Funds plc - Biotechnology Fund Class I GBP Distribution Shares | GBP | Aktienfonds | - | 56.46 | -0.42% | +12.58% | +16.75% | +33.89% | +88.83% |
| Pictet - Biotech - HZ CHF | CHF | Aktienfonds | - | 1'539.95 | +0.63% | +7.68% | +11.18% | +33.88% | +77.67% |
| Candriam Equities L Biotechnology, N-H - Thesaurierung | EUR | Aktienfonds | - | 225.50 | -0.47% | +12.86% | +15.91% | +33.84% | - |
| JPMorgan Funds - Thematics - Genetic Therapies C (acc) - CHF (hedged) | CHF | Aktienfonds | - | 94.36 | +0.36% | +17.17% | +21.15% | +33.81% | +28.12% |
| Pictet - Biotech - HR EUR | EUR | Aktienfonds | - | 709.36 | +0.60% | +7.51% | +11.11% | +33.53% | +76.15% |
| Polar Capital Funds plc - Biotechnology Fund Class R GBP Distribution Shares | GBP | Aktienfonds | - | 53.30 | -0.43% | +12.16% | +16.45% | +33.22% | +86.36% |
| JPMorgan Funds - Thematics - Genetic Therapies A (dist) - CHF (hedged) | CHF | Aktienfonds | - | 111.43 | +0.36% | +16.78% | +20.85% | +33.19% | +26.36% |
| JPMorgan Funds - Thematics - Genetic Therapies A (acc) - CHF (hedged) | CHF | Aktienfonds | - | 111.50 | +0.36% | +16.77% | +20.85% | +33.18% | +26.36% |
| Galileo - Biotech Innovation Fund IM USD | USD | Aktienfonds | - | 150.88 | +0.23% | +21.84% | +27.35% | +32.98% | +38.42% |
| Franklin Biotechnology Discovery Fund - F (acc) JPY-H1 | JPY | Aktienfonds | - | 1'604.10 | -0.66% | +7.84% | +13.18% | +32.93% | - |
| Franklin Biotechnology Discovery Fund - A (acc) CHF-H1 | CHF | Aktienfonds | - | 23.67 | -0.67% | +7.74% | +13.04% | +32.90% | +77.17% |
| Polar Capital Funds plc - Biotechnology Fund Class S USD Distribution Shares | USD | Aktienfonds | - | 77.19 | -0.66% | +10.89% | +17.10% | +32.24% | +106.56% |
| Candriam Equities L Biotechnology, R-H - Capitalisation | CHF | Aktienfonds | - | 295.51 | -0.47% | +11.78% | +15.06% | +32.18% | +65.29% |
| Polar Capital Funds plc - Biotechnology Fund Class I USD Distribution Shares | USD | Aktienfonds | - | 74.62 | -0.67% | +10.63% | +16.90% | +31.86% | +104.44% |
| Pictet - Biotech - HP CHF | CHF | Aktienfonds | - | 942.73 | +0.62% | +6.18% | +10.14% | +31.39% | +67.92% |
| Polar Capital Funds plc - Biotechnology Fund Class I Hedged GBP Distribution Shares | GBP | Aktienfonds | - | 29.31 | -0.68% | +10.19% | +16.49% | +31.26% | +100.75% |
| Polar Capital Funds plc - Biotechnology Fund Class R USD Distribution Shares | USD | Aktienfonds | - | 70.44 | -0.68% | +10.20% | +16.60% | +31.22% | +101.83% |
| Protea Fund - Sectoral Biotech Opportunities Fund PF EUR | EUR | Aktienfonds | - | 12.11 | +0.75% | +10.69% | +12.23% | +30.64% | +40.00% |
| Protea Fund - Sectoral Biotech Opportunities Fund IF USD | USD | Aktienfonds | - | 13.65 | +0.44% | +7.82% | +11.70% | +27.81% | +54.76% |
| Bellevue Biotech DT CHF | CHF | Aktienfonds | - | 4'713.23 | +0.89% | +11.49% | +17.22% | +27.44% | +41.00% |
| Bellevue Biotech CA CHF | CHF | Aktienfonds | - | 134.40 | +0.89% | +11.24% | +17.04% | +27.07% | +39.80% |
| Bellevue Biotech AA CHF | CHF | Aktienfonds | - | 4'265.24 | +0.89% | +10.99% | +16.87% | +26.68% | +38.48% |
| Protea Fund - Sectoral Biotech Opportunities Fund PF USD | USD | Aktienfonds | - | 12.25 | +0.33% | +6.99% | +11.06% | +26.42% | +50.31% |
| HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund P Cap USD | USD | Aktienfonds | - | 679.30 | +0.43% | +7.18% | +14.66% | +24.44% | +74.03% |
| HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund A Cap USD | USD | Aktienfonds | - | 653.02 | +0.43% | +6.78% | +14.38% | +23.65% | +70.97% |
| Bellevue Funds (Lux) - Bellevue Obesity Solutions I2 CHF - Accumulating | CHF | Aktienfonds | - | 146.78 | +0.56% | +9.59% | +17.52% | +22.16% | - |
| Bellevue Funds (Lux) - Bellevue Obesity Solutions I CHF - Accumulating | CHF | Aktienfonds | - | 469.54 | +0.56% | +9.48% | +17.43% | +21.99% | +6.41% |
| Protea Fund - Sectoral Biotech Opportunities Fund IF H CHF | CHF | Aktienfonds | - | 11.17 | +0.27% | +3.81% | +8.87% | +21.41% | - |
| Bellevue Funds (Lux) - Bellevue Obesity Solutions B CHF - Accumulating | CHF | Aktienfonds | - | 411.65 | +0.55% | +8.91% | +17.03% | +21.14% | +4.19% |
| Bellevue Funds (Lux) - Bellevue Obesity Solutions I2 EUR - Accumulating | EUR | Aktienfonds | - | 176.97 | +0.44% | +7.85% | +13.99% | +20.86% | +9.38% |
| Bellevue Funds (Lux) - Bellevue Obesity Solutions I EUR - Accumulating | EUR | Aktienfonds | - | 754.47 | +0.44% | +7.73% | +13.91% | +20.68% | +8.95% |
| Bellevue Funds (Lux) - Bellevue Obesity Solutions B EUR - Accumulating | EUR | Aktienfonds | - | 662.62 | +0.44% | +7.18% | +13.51% | +19.85% | +6.68% |
| Bellevue Funds (Lux) - Bellevue Obesity Solutions I GBP - Accumulating | GBP | Aktienfonds | - | 510.62 | +0.07% | +5.83% | +12.46% | +18.42% | +7.91% |
| Bellevue Funds (Lux) - Bellevue Obesity Solutions I2 USD - Accumulating | USD | Aktienfonds | - | 153.40 | +0.12% | +4.35% | +12.99% | +17.08% | - |
| Bellevue Funds (Lux) - Bellevue Obesity Solutions I USD - Accumulating | USD | Aktienfonds | - | 640.23 | +0.11% | +4.25% | +12.90% | +16.92% | +17.22% |
| Bellevue Funds (Lux) - Bellevue Obesity Solutions B USD - Accumulating | USD | Aktienfonds | - | 564.29 | +0.11% | +3.70% | +12.51% | +16.11% | +14.77% |
| CPR Invest - Biodiversity - IF2 EUR - Acc | EUR | Aktienfonds | - | 1'527.10 | -0.11% | +15.04% | +19.92% | +15.11% | - |
| CPR Invest - Biodiversity - A EUR - Acc | EUR | Aktienfonds | - | 122.64 | -0.12% | +13.97% | +19.17% | +13.76% | - |
| MEDICAL BioInnovation Fund Class USD | USD | Aktienfonds | - | 220.81 | -1.08% | +1.40% | +14.61% | +13.10% | +63.70% |
| CPR Invest - Biodiversity - IF1 EURH1 - Acc | EUR | Aktienfonds | - | 1'521.45 | -0.37% | +11.08% | +18.24% | +11.94% | - |
| CPR Invest - Biodiversity - IF2 EURH1 - Acc | EUR | Aktienfonds | - | 1'387.48 | -0.37% | +10.91% | +18.12% | +11.73% | - |
| Mirova Biodiversity Equity Z-NPF/A (EUR) | EUR | Aktienfonds | - | 104.74 | -0.05% | +4.58% | +6.27% | +4.79% | - |
| Mirova Biodiversity Equity R-NPF/A (EUR) | EUR | Aktienfonds | - | 97.79 | -0.06% | +3.09% | +5.25% | +2.80% | - |
| Candriam Equities L Biotechnology, I2 - Capitalisation | EUR | Aktienfonds | - | 1'724.30 | -0.25% | - | +15.08% | - | - |
| CPR Invest - Biodiversity - A USD - Acc | USD | Aktienfonds | - | 171.16 | -0.45% | +10.28% | +18.12% | - | - |
| CPR Invest - Biodiversity - F EUR - Acc | EUR | Aktienfonds | - | 133.02 | -0.13% | +13.11% | +18.59% | - | - |
| CPR Invest - Biodiversity - I EUR - Acc | EUR | Aktienfonds | - | 117.34 | -0.11% | +14.69% | +19.69% | - | - |
| CPR Invest - Biodiversity - U EUR - Acc | EUR | Aktienfonds | - | 148.08 | -0.12% | +13.33% | +18.74% | - | - |
| Polar Capital Funds plc - Biotechnology Fund Class R USD Accumulating Shares | USD | Aktienfonds | - | 10.63 | -0.65% | +10.04% | +16.43% | - | - |
| Janus Henderson Horizon Biotechnology Fund H2 EUR | EUR | Aktienfonds | - | 32.50 | +1.25% | - | +8.33% | - | - |